Molecular Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The molecular breast imaging (MBI) sector is expected to grow significantly, achieving a CAGR of 6.95% from 2025 to 2032. The market, anticipated to reach USD 890.86 million by 2025 and USD 1,425.91 million by 2032, is driven by technological progress and an increased emphasis on early detection of breast cancer. MBI is emerging as a key diagnostic tool, particularly for women with dense breast tissue, helping to enhance early cancer diagnosis while minimizing false positives.

Market Insights

Molecular breast imaging is a diagnostic method that employs a radioactive tracer to highlight cellular activities in breast tissue. Unlike traditional mammography, MBI provides metabolic and functional insights, improving diagnostic accuracy. The growing incidence of breast cancer and continual advancements in imaging technology are fueling demand for MBI solutions. Continuous research and development efforts aim to refine imaging precision, driving broader adoption worldwide.

Key Market Drivers

1. Improvements in Imaging Technology – The introduction of digital detectors and advanced image-processing algorithms enhances the accuracy and sensitivity of MBI.

2. Shift Toward Personalized Medicine – The rising adoption of tailored treatment strategies makes MBI crucial in individualized cancer management plans.

3. Growing Awareness and Screening Initiatives – Governmental and healthcare programs promoting routine screenings are bolstering market growth.

4. Rising Breast Cancer Incidence – The increasing prevalence of breast cancer worldwide necessitates more advanced imaging methods like MBI.

Business Opportunities

1. Expanding Applications Beyond Breast Cancer Diagnosis – MBI's potential for identifying other medical conditions presents significant market expansion opportunities.

2. Integration with Artificial Intelligence (AI) – AI-powered analytics can process MBI images more effectively, enhancing diagnostic accuracy and efficiency.

3. Strategic Collaborations and Partnerships – Partnerships between MBI manufacturers and AI firms are driving market differentiation and innovation.

Market Restraints

1. Regulatory and Safety Concerns – The use of radioactive tracers mandates strict regulatory compliance, which may slow new product approvals.

2. High Costs and Limited Access – The substantial cost of acquiring and operating MBI systems poses challenges, especially in resource-constrained regions.

3. Uneven Healthcare Infrastructure – The lack of widespread MBI accessibility in underserved regions limits its adoption.

Regional Insights
• North America continues to lead the market due to its well-developed healthcare system, widespread breast cancer awareness, and swift adoption of advanced medical technologies.
• East Asia is experiencing the fastest growth, driven by healthcare modernization, increasing breast cancer prevalence, and supportive government policies.
• Europe, Latin America, and the Middle East & Africa are also seeing steady market growth, bolstered by increasing healthcare investments and technological advancements.

Key Industry Players

Leading companies in the molecular breast imaging sector are focusing on R&D, innovation, and strategic partnerships. Major players include:
• Koninklijke Philips N.V. (Netherlands)
• Hitachi Ltd. (Japan)
• Siemens Healthcare GmbH (Germany)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• General Electric (US)
• Aspect Imaging Ltd (Israel)
• Bruker (US)
• Aurora Health Care (US)
• FONAR Corp. (US)
• ESAOTE SPA (Italy)
• Neusoft Corporation (China)
• TOSHIBA CORPORATION (Japan)

Market Segmentation

1. By Modality:

o Single Head Gamma Camera

o Dual Head Camera

2. By Imaging Technique:

o Planar Imaging

o SPECT Imaging

3. By Application:

o Screening

o Diagnosis

o Others (Research & Development)

4. By End User:

o Hospitals

o Diagnostic Imaging Centers

o Breast Cancer Care Facilities

5. By Region:

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East & Africa

Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Molecular Breast Imaging Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Molecular Breast Imaging Market Outlook, 2019 - 2032
3.1. Global Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Single Head Gamma Camera
3.1.1.2. Dual Head Camera
3.2. Global Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Planar Imaging
3.2.1.2. SPECT Imaging
3.3. Global Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. Screening
3.3.1.2. Diagnosis
3.3.1.3. Others (such as research and development)
3.4. Global Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
3.4.1. Key Highlights
3.4.1.1. Hospital
3.4.1.2. Diagnostic Imaging Centers
3.4.1.3. Breast Cancer Care
3.5. Global Molecular Breast Imaging Market Outlook, by Region, Value (US$ Mn), 2019 - 2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Molecular Breast Imaging Market Outlook, 2019 - 2032
4.1. North America Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Single Head Gamma Camera
4.1.1.2. Dual Head Camera
4.2. North America Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Planar Imaging
4.2.1.2. SPECT Imaging
4.3. North America Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Screening
4.3.1.2. Diagnosis
4.3.1.3. Others (such as research and development)
4.4. North America Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. Hospital
4.4.1.2. Diagnostic Imaging Centers
4.4.1.3. Breast Cancer Care
4.5. North America Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
4.5.1. Key Highlights
4.5.1.1. U.S. Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
4.5.1.2. U.S. Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
4.5.1.3. U.S. Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
4.5.1.4. U.S. Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
4.5.1.5. Canada Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
4.5.1.6. Canada Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
4.5.1.7. Canada Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
4.5.1.8. Canada Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Molecular Breast Imaging Market Outlook, 2019 - 2032
5.1. Europe Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Single Head Gamma Camera
5.1.1.2. Dual Head Camera
5.2. Europe Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Planar Imaging
5.2.1.2. SPECT Imaging
5.3. Europe Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Screening
5.3.1.2. Diagnosis
5.3.1.3. Others (such as research and development)
5.4. Europe Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Hospital
5.4.1.2. Diagnostic Imaging Centers
5.4.1.3. Breast Cancer Care
5.5. Europe Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
5.5.1. Key Highlights
5.5.1.1. Germany Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.2. Germany Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.3. Germany Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.4. Germany Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.5. U.K. Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.6. U.K. Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.7. U.K. Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.8. U.K. Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.9. France Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.10. France Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.11. France Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.12. France Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.13. Italy Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.14. Italy Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.15. Italy Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.16. Italy Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.17. Turkey Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.18. Turkey Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.19. Turkey Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.20. Turkey Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.21. Russia Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.22. Russia Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.23. Russia Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.24. Russia Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.25. Rest of Europe Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
5.5.1.26. Rest of Europe Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
5.5.1.27. Rest of Europe Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
5.5.1.28. Rest of Europe Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Molecular Breast Imaging Market Outlook, 2019 - 2032
6.1. Asia Pacific Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Single Head Gamma Camera
6.1.1.2. Dual Head Camera
6.2. Asia Pacific Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Planar Imaging
6.2.1.2. SPECT Imaging
6.3. Asia Pacific Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Screening
6.3.1.2. Diagnosis
6.3.1.3. Others (such as research and development)
6.4. Asia Pacific Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. Hospital
6.4.1.2. Diagnostic Imaging Centers
6.4.1.3. Breast Cancer Care
6.5. Asia Pacific Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
6.5.1. Key Highlights
6.5.1.1. China Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
6.5.1.2. China Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.5.1.3. China Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
6.5.1.4. China Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.5. Japan Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
6.5.1.6. Japan Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.5.1.7. Japan Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
6.5.1.8. Japan Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.9. South Korea Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
6.5.1.10. South Korea Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.5.1.11. South Korea Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
6.5.1.12. South Korea Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.13. India Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
6.5.1.14. India Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.5.1.15. India Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
6.5.1.16. India Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.17. Southeast Asia Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
6.5.1.18. Southeast Asia Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.5.1.19. Southeast Asia Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
6.5.1.20. Southeast Asia Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.21. Rest of Asia Pacific Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
6.5.1.22. Rest of Asia Pacific Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
6.5.1.23. Rest of Asia Pacific Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
6.5.1.24. Rest of Asia Pacific Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Molecular Breast Imaging Market Outlook, 2019 - 2032
7.1. Latin America Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Single Head Gamma Camera
7.1.1.2. Dual Head Camera
7.2. Latin America Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032
7.2.1.1. Planar Imaging
7.2.1.2. SPECT Imaging
7.3. Latin America Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Screening
7.3.1.2. Diagnosis
7.3.1.3. Others (such as research and development)
7.4. Latin America Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Hospital
7.4.1.2. Diagnostic Imaging Centers
7.4.1.3. Breast Cancer Care
7.5. Latin America Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
7.5.1. Key Highlights
7.5.1.1. Brazil Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
7.5.1.2. Brazil Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
7.5.1.3. Brazil Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
7.5.1.4. Brazil Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
7.5.1.5. Mexico Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
7.5.1.6. Mexico Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
7.5.1.7. Mexico Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
7.5.1.8. Mexico Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
7.5.1.9. Argentina Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
7.5.1.10. Argentina Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
7.5.1.11. Argentina Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
7.5.1.12. Argentina Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
7.5.1.13. Rest of Latin America Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
7.5.1.14. Rest of Latin America Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
7.5.1.15. Rest of Latin America Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
7.5.1.16. Rest of Latin America Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Molecular Breast Imaging Market Outlook, 2019 - 2032
8.1. Middle East & Africa Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Single Head Gamma Camera
8.1.1.2. Dual Head Camera
8.2. Middle East & Africa Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Planar Imaging
8.2.1.2. SPECT Imaging
8.3. Middle East & Africa Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Screening
8.3.1.2. Diagnosis
8.3.1.3. Others (such as research and development)
8.4. Middle East & Africa Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. Hospital
8.4.1.2. Diagnostic Imaging Centers
8.4.1.3. Breast Cancer Care
8.5. Middle East & Africa Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
8.5.1. Key Highlights
8.5.1.1. GCC Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
8.5.1.2. GCC Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
8.5.1.3. GCC Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
8.5.1.4. GCC Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.5. South Africa Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
8.5.1.6. South Africa Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
8.5.1.7. South Africa Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
8.5.1.8. South Africa Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.9. Egypt Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
8.5.1.10. Egypt Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
8.5.1.11. Egypt Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
8.5.1.12. Egypt Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.13. Nigeria Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
8.5.1.14. Nigeria Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
8.5.1.15. Nigeria Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
8.5.1.16. Nigeria Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.17. Rest of Middle East & Africa Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032
8.5.1.18. Rest of Middle East & Africa Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032
8.5.1.19. Rest of Middle East & Africa Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032
8.5.1.20. Rest of Middle East & Africa Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. by Application vs by Imaging Technique Heat map
9.2. Manufacturer vs by Imaging Technique Heat map
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Koninklijke Philips N.V.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Hitachi Ltd.
9.5.3. Siemens Healthcare GmbH
9.5.4. CANON MEDICAL SYSTEMS CORPORATION
9.5.5. General Electric
9.5.6. Aspect Imaging Ltd
9.5.7. Bruker
9.5.8. Aurora Health Care
9.5.9. FONAR Corp.
9.5.10. ESAOTE SPA
9.5.11. Neusoft Corporation
9.5.12. TOSHIBA CORPORATION
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings